GEODE CAPITAL MANAGEMENT, LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in ARWR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$287,780,183
+$19,497,668 QoQ
Shares Held
3,530,612
-17.5% QoQ
Ownership
2.50%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#9
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,415,676 across 520 Biotechnology names. ARWR ranks #14 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $287,780,183 | 3,530,612 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $268,282,515 | 4,278,828 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $216,760,893 | 3,264,963 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $107,989,638 | 3,131,042 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $47,060,378 | 2,978,505 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $37,586,974 | 2,950,312 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $55,553,003 | 2,954,947 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $57,414,984 | 2,964,119 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $76,357,267 | 2,937,948 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $78,782,532 | 2,754,634 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $71,202,405 | 2,326,876 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $59,604,458 | 2,218,253 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $76,777,763 | 2,153,050 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $52,794,585 | 2,078,527 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $80,047,228 | 1,973,551 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $62,378,470 | 1,887,397 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $65,186,984 | 1,851,377 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $85,308,276 | 1,854,931 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $120,394,170 | 1,815,900 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $111,773,236 | 1,790,377 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $149,804,981 | 1,808,802 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $116,474,178 | 1,756,510 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $123,402,787 | 1,608,273 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $65,805,497 | 1,528,228 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $67,136,954 | 1,554,456 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $43,605,049 | 1,515,643 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||